Rationale and design of AXAFA-AFNET 5: An investigator-initiated, randomized, open, blinded outcome assessment,multi-centre trial to comparing continuous apixaban to Vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation

Luigi Di Biase, David Callans, Karl Georg Husler, Gerhard Hindricks, Hussein Al-Khalidi, Lluis Mont, Jens Cosedis Nielsen, Jonathan P. Piccini, Ulrich Schotten, Paulus Kirchhof

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and design of AXAFA-AFNET 5: An investigator-initiated, randomized, open, blinded outcome assessment,multi-centre trial to comparing continuous apixaban to Vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation'. Together they form a unique fingerprint.

Medicine & Life Sciences